Clinical Trial Update: Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)

View source ↗

Summary

This clinical trial update presents real-world outcomes after initiating Trixeo (budesonide/glycopyrronium/formoterol) for chronic obstructive pulmonary disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trixeo

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED